| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.26 | 0.08 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |